Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2020-12-01
|
| Schriftenreihe: | Pharmaceutics |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1999-4923/12/12/1205 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|